Overview Executive Committee Supervisory Board Locations
Overview Satraplatin Kinase Inhibitors
Stock Major Shareholdings Key Figures Financial Reports SEC Filings

Corporate Governance

Analyst Coverage Shareholder´s Meeting Webcasts Information Request
Press Releases Contact Information
Working for GPC Biotech Germany USA

More Info

Corporate Governance Declarations

Code of Conduct

Disclosure Committee

Management and Control Structures

Compensation of the Boards

Shareholdings of the Boards

Directors' Dealings

Print preview

Back

Print

Investor Relations


Corporate Governance | Shareholdings of the Boards

Shareholdings of the Mangement Board as of June 30, 2008

-

Number of shares

Number of options

Number of convertible bonds

Bernd R. Seizinger, M.D., Ph.D.

111,499

789,000

1,413,501

Torsten Hombeck, Ph.D.

-

172,700

45,000

 

 

 

Shareholdings of the Supervisory Board as of June 30, 2008

-

Number of shares

Number of options

Number of convertible bonds

Number of stock appreciation rights

Jürgen Drews, M.D.

26,900

10,000

-

80,000

Michael Lytton, J.D.

7,500

10,000

-

60,000

Metin Colpan, Ph.D.

19,400

10,000

-

45,000

Donald Soltysiak

-

-

-

10,000

James M. Frates

1,000

-

-

60,000

Peter Preuss

87,500

-

-

50,000

 

Investor Relations | Corporate Governance